Sign in to continue:

Friday, March 6th, 2026

Author: Minichart

us corporate news

Ameris Bancorp (ABCB) 8-K SEC Filing Cover Page, Company Info & Trading Details – February 19, 2026

Minichart
February 25, 2026

Ameris Bancorp Files Form 8-K: Departure of Director, Officer Changes, and Compensatory Arrangements Key Highlights: Ameris Bancorp (NYSE: ABCB) filed a Form 8-K with the SEC dated February 24, 2026, reporting significant corporate governance...

Continue Reading 0
us corporate news

Paloma Acquisition Corp I Announces $150 Million IPO and Nasdaq Listing Focused on U.S. Gold & Silver Sector 1

Minichart
February 25, 2026

Paloma Acquisition Corp I Announces Pricing of \$150 Million IPO Paloma Acquisition Corp I Announces Pricing of \$150 Million Initial Public Offering Date: February 18, 2026 Location: New York, NY Key Highlights from the...

Continue Reading 0
us corporate news

Concentrix Corporation 8-K Filing Details: Company Information, SEC Registration, and XBRL Data (Feb 24, 2026)

Minichart
February 25, 2026

Concentrix Corporation Announces \$600 Million Offering of 6.500% Senior Notes Due 2029 Key Highlights from the Latest SEC Filing Issuer: Concentrix Corporation (NASDAQ: CNXC) Type of Security: \$600,000,000 aggregate principal amount of 6.500% Senior...

Continue Reading 0
us corporate news

Cardiff Oncology Reports Positive Phase 2 Results for Onvansertib in RAS-Mutated mCRC and Provides 2025 Financial Update

Minichart
February 25, 2026

Cardiff Oncology Reports Full Year 2025 Results & Business Update: Major Clinical Milestone in Metastatic Colorectal Cancer Cardiff Oncology Reports Full Year 2025 Results & Business Update: Major Clinical Milestone in Metastatic Colorectal Cancer...

Continue Reading 0
us corporate news

CNX Resources Announces Tender Offer Results and Redemption Plan for 6.000% Senior Notes Due 2029

Minichart
February 25, 2026

CNX Resources Corporation Announces Final Results and Expiration of 2029 Notes Tender Offer CNX Resources Corporation Announces Final Results and Expiration of Tender Offer for 6.000% Senior Notes Due 2029 PITTSBURGH, February 23, 2026...

Continue Reading 0
us corporate news

MGE Energy, Inc. SEC Filing: Prospectus Supplement and Sales Agreement with Guggenheim Securities and Morgan Stanley (February 2026)

Minichart
February 25, 2026

MGE Energy, Inc. Files Equity Distribution Agreement – Key Details for Investors MGE Energy, Inc. Announces Equity Distribution Agreement: Key Details for Investors MGE Energy, Inc. (NASDAQ: MGEE) has filed a Form 8-K with...

Continue Reading 0
us corporate news

Wyndham Hotels & Resorts Announces $650 Million Senior Notes Offering to Repay Debt and Support Corporate Growth

Minichart
February 25, 2026

Wyndham Hotels & Resorts Announces \$650 Million Senior Notes Offering Wyndham Hotels & Resorts Announces \$650 Million Senior Notes Offering Key Points for Investors Wyndham Hotels & Resorts, Inc. (NYSE: WH) has announced its...

Continue Reading 0
us corporate news

CDT Equity Inc. and Sarborg Limited Securities Purchase Agreement: Common Stock, Pre-Funded Warrants, and Transaction Details

Minichart
February 25, 2026

CDT Equity Inc. Announces Private Placement and Acquisition of Sarborg Limited Shares CDT Equity Inc. Announces Strategic Private Placement and Acquisition of Sarborg Limited Shares Key Highlights Private Placement: CDT Equity Inc. (the “Company”)...

Continue Reading 0
us corporate news

VenHub Global, Inc. (VHUB) Files 8-K Current Report with Nasdaq Listing and Company Details – February 24, 2026

Minichart
February 25, 2026

VenHub Global, Inc. Issues Clarification on Direct Listing Compensation Disclosure VenHub Global, Inc. (NASDAQ: VHUB) has released a Current Report on Form 8-K dated February 24, 2026, to clarify important details regarding the compensation...

Continue Reading 0
us corporate news

Artiva Biotherapeutics, Inc. SEC Form 8-K Filing Details for January 2025 – Company Information, Trading Symbol, and Emerging Growth Status

Minichart
February 25, 2026

Artiva Biotherapeutics, Inc. Announces Departure and Appointment of Chief Financial Officer San Diego, CA – February 24, 2026 – Artiva Biotherapeutics, Inc. (NASDAQ: ARTV), a clinical-stage company specializing in biological products, has filed a...

Continue Reading 0